Evidence map›Paper›PMID 41726096›Full record

ArticlePatterns (New York, N.Y.)2026

A self-supervised framework for emphysema anomaly detection and staging in computed tomography scans.

Xiang Zhang, Mingyue Zhao, Fei Yao, Wenxin Ma, Jin Zhang, Yueze Li, Xiuxiu Zhou, Yu Guan, Yi Xiao, Li Fan and 2 more

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiang ZhangSchool of Medicine, Shanghai University, Shanghai 200444, China.
Mingyue ZhaoCenter for Medical Imaging, Robotics, Analytic Computing & Learning (MIRACLE), Suzhou Institute for Advanced Research, University of Science and Technology of China (USTC), Suzhou, Jiangsu 215123, China.
Fei YaoSchool of Medicine, Shanghai University, Shanghai 200444, China.
Wenxin MaCenter for Medical Imaging, Robotics, Analytic Computing & Learning (MIRACLE), Suzhou Institute for Advanced Research, University of Science and Technology of China (USTC), Suzhou, Jiangsu 215123, China.
Jin ZhangDepartment of Radiology, Second Affiliated Hospital of Navy Medical University, Shanghai 200003, China.
Yueze LiDepartment of Radiology, Second Affiliated Hospital of Navy Medical University, Shanghai 200003, China.
Xiuxiu ZhouDepartment of Radiology, Second Affiliated Hospital of Navy Medical University, Shanghai 200003, China.
Yu GuanDepartment of Radiology, Second Affiliated Hospital of Navy Medical University, Shanghai 200003, China.
Yi XiaoDepartment of Radiology, Second Affiliated Hospital of Navy Medical University, Shanghai 200003, China.
Li FanDepartment of Radiology, Second Affiliated Hospital of Navy Medical University, Shanghai 200003, China.
Shaohua Kevin ZhouCenter for Medical Imaging, Robotics, Analytic Computing & Learning (MIRACLE), Suzhou Institute for Advanced Research, University of Science and Technology of China (USTC), Suzhou, Jiangsu 215123, China.
Shiyuan LiuSchool of Medicine, Shanghai University, Shanghai 200444, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emphysema, a diffuse and heterogeneous phenotype of chronic obstructive pulmonary disease (COPD), carries substantial morbidity and elevates lung cancer risk. While computed tomography (CT) aids in detection and monitoring, current deep learning methods depend on large annotated datasets. Unsupervised anomaly detection (UAD) provides an alternative but faces challenges with emphysema anomalies and weak emphysema semantics. In this study, we propose a self-supervised framework trained exclusively on non-emphysema CT scans using synthetically generated lesions to guide pixel-level anomaly modeling. We introduce EDLNet, an encoder-decoder architecture with spatial-channel refinement and adaptive feature fusion for emphysema detection and localization, followed by an unsupervised manner for emphysema staging. Multi-center evaluations show that our framework outperforms existing UAD approaches in detection and localization, while achieving a mean staging accuracy of 93.13% and a macro AUROC of 99.08%. This approach bridges clinical knowledge and artificial intelligence, offering a scalable and interpretable solution for lung disease analysis.

Indexed as

emphysemalesion synthesisunsupervised anomaly detectionunsupervised staging

Identifiers

PMID41726096
PMCPMC12921507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.